Reader,
You probably know me as the guy who hosts all of our live events.
But it’s also part of my role here at Stansberry Research to follow the trends our readers want to hear about or should hear about… Topics like Bitcoin or Dr. Steve Sjuggerud's Melt Up Thesis.
To find these profitable ideas, I'm an avid reader… and I love trying new things.
For example, I taught myself how to trade options with our research, and now I'm testing out cryptocurrencies.
So when Porter Stansberry asked me to host an event about cancer, I was nervous.
I thought to myself, "People don't want to hear about cancer. I certainly don't…"
Personally, I'm a healthy eater, I exercise, and I sleep eight hours a day whenever I can. I don't want to think about getting sick… ever.
And I'm sure you don't, either.
But then Porter and biotech expert Dave Lashmet showed me a radical new cancer breakthrough. And it opened my eyes.
Frankly, I hadn't realized how much cancer treatment has changed in recent years.
(And how much money you could make in this sector right now.)
You see, Dave Lashmet has been studying cancer medicine for 20 years. He's seen just about every breakthrough along the way. (Including ID Biomedical, which is up more than 1,000% since he first wrote about it.)
But today, he believes his newest discovery could change cancer medicine forever… and make early investors huge gains.
Pretty exciting, considering that since launching his latest venture, Dave's recommended eight companies which quickly rallied at least 100%, some of which are still open recommendations and climbing.
That's why I think this is going to be one of the biggest nights in Stansberry Research history.
But it might also be the most controversial.
A lot of folks might find it strange that we're hosting a live event about cancer.
But I promise you, this event will change everything you know about modern medicine.
Even if you don't take us up on the recommendation that could make you up to 5-times your money, the information you learn could save your life or someone you love.
To learn more about this Wednesday's event and sign up, click here.
Regards,
Jared Kelly Managing Director Stansberry Research |